[col_23]

A qualitative ELISA for the detection of fecal lactoferrin.

 

[image source=”https://www.techlab.com/wp-content/uploads/2013/06/t5008.jpg” alt=”IBD-CHEK align=”right” border=”true”]

The IBD-CHEK® is an ELISA for the qualitative detection of elevated levels of lactoferrin, a marker for fecal leukocytes and an indicator of intestinal inflammation. The test can be used as an in vitro diagnostic aid to identify patients with active inflammatory bowel disease (IBD) and rule out those with active irritable bowel syndrome (IBS), which is noninflammatory.

IBD, which is a condition of chronic inflammation, consists of ulcerative colitis and Crohn’s disease. Both of these diseases result in elevated fecal lactoferrin. As a result, patients with these diseases test positive in the IBD-CHEK® test. In patients with active IBS, the intestine appears normal upon endoscopic examination and there is no indication of inflammation. As a result, IBS patients test negative in the IBD-CHEK® test. The IBD-CHEK® test is a simple-to-use microwell format that has a turnaround time of an hour and fifteen minutes.

 

Further Information

Package Insert (PDF) Issued 4/08

CPT Codes (PDF) Issued 02/2023

Material Safety Data Sheet (PDF) Issued 10/13

Declaration of Conformity (PDF) Issued 08/14

Poster Presentation (PDF)
Clinical Evaluation of the IBD-CHEK® Test for Detecting Elevated Fecal Lactoferrin as an Indicator of Intestinal Inflammation in Pediatric Patients
Digestive Disease Week, May 2003, Orlando, FL

[/col_23]

[col_14_last]

Features

[arrowlist]

  • Rapid screen to determine presence of intestinal inflammation
  • Highly standardized
  • Accurate measurement of both solid and liquid fecal samples using novel pipet design
  • Results in approximately 75 minutes

[/arrowlist]

This product is available exclusively through our global distributor, Alere.

[/col_14_last]